ORAL product line
ACAMPROSATE CA
|
Midodrine (outside USA) |
| Amantadine HCl USP |
Misoprostol |
BUDESONIDE
|
Nateglinide |
| BUMETANIDE |
Nisoldipine** |
| Clindamycin HCl USP/PhEur |
Ondansetron HCl USP |
| Doxercalciferol |
Ondansetron Base USP** |
| Doxycycline Hyclate |
Procarbazine HCl |
| Ethosuximide USP |
Sirolimus** |
| Granisetron HCl** |
Tacrolimus |
| Griseofulvin USP |
Tiagabine HCl |
| Isradipine USP |
Tizanidine HCl USP |
| Lovastatin USP |
Topiramate** |
| Medroxyprogesterone Acetate USP |
|
Items denoted by blue text have been approved in the USA/EC
** Pending Approval
chemwerth's goal is to offer the best source – not the first source. Using chemwerth's APIs, you will receive the fastest FDA approval possible which is critical to your success in the highly competitive generic oral market. Our Regulatory expertise allows for customers to receive FDA approval in 12 to 15 months.
E-Mail: chemwerth@chemwerth.com
|